Show simple item record

dc.contributor.authorMangiavacchi, Arianna
dc.contributor.authorSorci, Melissa
dc.contributor.authorMasciarelli, Silvia
dc.contributor.authorLarivera, Simone
dc.contributor.authorLegnini, Ivano
dc.contributor.authorIosue, Ilaria
dc.contributor.authorBozzoni, Irene
dc.contributor.authorFazi, Francesco
dc.contributor.authorFatica, Alessandro
dc.date.accessioned2016-11-03T07:43:57Z
dc.date.available2016-11-03T07:43:57Z
dc.date.issued2016-08-09
dc.identifier.citationMangiavacchi A, Sorci M, Masciarelli S, Larivera S, Legnini I, et al. (2016) The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA. Oncotarget. Available: http://dx.doi.org/10.18632/oncotarget.11165.
dc.identifier.issn1949-2553
dc.identifier.pmid27517498
dc.identifier.doi10.18632/oncotarget.11165
dc.identifier.urihttp://hdl.handle.net/10754/621271
dc.description.abstractAlterations in genetic programs required for terminal myeloid differentiation and aberrant proliferation characterize acute myeloid leukemia (AML) cells. Here, we identify the host transcript of miR-223, linc-223, as a novel functional long non-coding RNA (lncRNA) in AML. We show that from the primary nuclear transcript, the alternative production of miR-223 and linc-223 is finely regulated during monocytic differentiation. Moreover, linc-223 expression inhibits cell cycle progression and promotes monocytic differentiation of AML cells. We also demonstrate that endogenous linc-223 localizes in the cytoplasm and acts as a competing endogenous RNA for miR-125-5p, an oncogenic microRNA in leukemia. In particular, we show that linc-223 directly binds to miR-125-5p and that its knockdown increases the repressing activity of miR-125-5p resulting in the downregulation of its target interferon regulatory factor 4 (IRF4), which it was previously shown to inhibit the oncogenic activity of miR-125-5p in vivo. Furthermore, data from primary AML samples show significant downregulation of linc-223 in different AML subtypes. Therein, these findings indicate that the newly identified lncRNA linc-223 may have an important role in myeloid differentiation and leukemogenesis, at least in part, by cross-talking with IRF4 mRNA.
dc.description.sponsorshipThe authors would like to thank Dr A. Rosa and Dr A. Brivanlou for the ePiggyBac inducible transposon system, A Sorrentino for the RNA from the human CD34+ progenitor cells, and M. Marchioni and M. Arceci for technical assistance. This work was supported by A.I.R.C. (IG 17352) and “Progetti Ateneo” Sapienza University of Rome to A.F.; and ERC-2013 (AdG 340172–MUNCODD), Epigen-Epigenomics Flagship Project, AFM-Telethon (17835), PRIN 2013, AriSLA full grant 2014 “ARCI” and HFSP (RGP0009/2014) to I.B. Contribution of AIRC (StG 4841) and FILAS-RU-2014-1020 to FF was greatly appreciated.
dc.publisherImpact Journals, LLC
dc.relation.urlhttp://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=11165
dc.rightsArchived with thanks to Impact Journals, LLC. The article is distributed under the terms of the Creative Commons Attribution 3.0 License.
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/
dc.subjectlong non-coding RNA
dc.subjectmiR-125
dc.subjectacute myeloid leukemia
dc.subjectIRF4
dc.titleThe miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA
dc.typeArticle
dc.contributor.departmentBiological and Environmental Sciences and Engineering (BESE) Division
dc.contributor.departmentKAUST Environmental Epigenetics Research Program (KEEP)
dc.identifier.journalOncotarget
dc.eprint.versionPublisher's Version/PDF
dc.contributor.institutionDepartment of Biology and Biotechnology “C. Darwiny”, Sapienza University of Rome, Rome, 00185, Italy
dc.contributor.institutionDepartment of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, Rome, 00185, Italy
dc.contributor.institutionCenter for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, 00161, Italy
dc.contributor.institutionInstitute Pasteur Fondazione Cenci-Bolognetti, Sapienza University of Rome, Rome, 00185, Italy
kaust.personMangiavacchi, Arianna
refterms.dateFOA2018-06-13T13:03:46Z
dc.date.published-online2016-08-09
dc.date.published-print2016-09-13


Files in this item

Thumbnail
Name:
10.18632_oncotarget.11165_main.pdf
Size:
1.825Mb
Format:
PDF
Description:
Main article
Thumbnail
Name:
10.18632_oncotarget.11165_supl1.pdf
Size:
1.060Mb
Format:
PDF
Description:
Supplement
Thumbnail
Name:
10.18632_oncotarget.11165_supl_table.xlsx
Size:
52.44Kb
Format:
Microsoft Excel 2007
Description:
Supplement

This item appears in the following Collection(s)

Show simple item record

Archived with thanks to Impact Journals, LLC. The article is distributed under the terms of the Creative Commons Attribution 3.0 License.
Except where otherwise noted, this item's license is described as Archived with thanks to Impact Journals, LLC. The article is distributed under the terms of the Creative Commons Attribution 3.0 License.